Solara Active Pharma Sciences Limited SOLARA.NS · Stock Open Solara Active Pharma Sciences Limited in new tab
Solara Active Pharma Sciences Limited Analysis (SOLARA.NS)
Is Solara Active Pharma Sciences Limited a good investment? Solara Active Pharma Sciences Limited (SOLARA.NS) is currently trading at 505.00 INR.
Earnings Schedule: Solara Active Pharma Sciences Limited is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 31.40.
Investor FAQ
Does Solara Active Pharma Sciences Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Solara Active Pharma Sciences Limited?
Solara Active Pharma Sciences Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of -1.62.
Company Profile
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
| Year | Total Dividends |
|---|---|
| ▸2021 |
3.00 INR
|
| Sept. 24, 2021 | 3.0000 |
| ▸2020 |
6.00 INR
|
| Dec. 11, 2020 | 4.0000 |
| Sept. 3, 2020 | 2.0000 |
| ▸2019 |
5.00 INR
|
| Sept. 13, 2019 | 5.0000 |
| Split Date | Split Ratio to 1 |
|---|---|
| May 15, 2024 | 1.080000 |
Community Discussion